Articoli con mandati relativi all'accesso pubblico - Patrick RyanUlteriori informazioni
Non disponibili pubblicamente: 18
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership
PB Ryan, D Madigan, PE Stang, J Marc Overhage, JA Racoosin, ...
Statistics in medicine 31 (30), 4401-4415, 2012
Mandati: US National Institutes of Health
Defining a reference set to support methodological research in drug safety
PB Ryan, MJ Schuemie, E Welebob, J Duke, S Valentine, AG Hartzema
Drug safety 36, 33-47, 2013
Mandati: US National Institutes of Health
Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system
PB Ryan, MJ Schuemie, S Gruber, I Zorych, D Madigan
Drug safety 36, 59-72, 2013
Mandati: US National Institutes of Health
Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system
GN Norén, T Bergvall, PB Ryan, K Juhlin, MJ Schuemie, D Madigan
Drug safety 36, 107-121, 2013
Mandati: US National Institutes of Health
Empirical performance of the case–control method: lessons for developing a risk identification and analysis system
D Madigan, MJ Schuemie, PB Ryan
Drug Safety 36, 73-82, 2013
Mandati: US National Institutes of Health
Evaluation of disproportionality safety signaling applied to healthcare databases
W DuMouchel, PB Ryan, MJ Schuemie, D Madigan
Drug safety 36, 123-132, 2013
Mandati: US National Institutes of Health
Alternative outcome definitions and their effect on the performance of methods for observational outcome studies
CG Reich, PB Ryan, MJ Schuemie
Drug safety 36, 181-193, 2013
Mandati: US National Institutes of Health
Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series
MJ Schuemie, G Trifiro, PM Coloma, PB Ryan, D Madigan
Statistical methods in medical research 25 (6), 2577-2592, 2016
Mandati: US National Institutes of Health
Evaluating performance of risk identification methods through a large-scale simulation of observational data
PB Ryan, MJ Schuemie
Drug safety 36, 171-180, 2013
Mandati: US National Institutes of Health
Managing data quality for a drug safety surveillance system
AG Hartzema, CG Reich, PB Ryan, PE Stang, D Madigan, E Welebob, ...
Drug safety 36, 49-58, 2013
Mandati: US National Institutes of Health
Desideratum for evidence based epidemiology
JM Overhage, PB Ryan, MJ Schuemie, PE Stang
Drug safety 36, 5-14, 2013
Mandati: US National Institutes of Health
Health outcomes of interest in observational data: issues in identifying definitions in the literature
PE Stang, PB Ryan, SB Dusetzina, AG Hartzema, C Reich, JM Overhage, ...
Health Outcomes Research in Medicine 3 (1), e37-e44, 2012
Mandati: US National Institutes of Health
Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system
MJ Schuemie, D Madigan, PB Ryan
Drug safety 36, 133-142, 2013
Mandati: US National Institutes of Health
Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey
PE Stang, PB Ryan, JM Overhage, MJ Schuemie, AG Hartzema, ...
Drug safety 36, 15-25, 2013
Mandati: US National Institutes of Health
Surveying US observational data sources and characteristics for drug safety needs
P Ryan, E Welebob, AG Hartzema, P Stang, JM Overhage
Pharmaceutical Medicine 24, 231-238, 2010
Mandati: US National Institutes of Health
Assessment of case definitions for identifying acute liver injury in large observational databases
AJ Katz, PB Ryan, JA Racoosin, PE Stang
Drug safety 36, 651-661, 2013
Mandati: US National Institutes of Health
Statistical visualization for assessing performance of methods for safety surveillance using electronic databases
X Li, S Hui, P Ryan, M Rosenman, M Overhage
Pharmacoepidemiology and drug safety 22 (5), 503-509, 2013
Mandati: US National Institutes of Health
Development and evaluation of infrastructure and analytic methods for systematic drug safety surveillance: lessons and resources from the observational medical outcomes partnership
P Stang, P Ryan, AG Hartzema, D Madigan, J Marc Overhage, E Welebob, ...
Mann's Pharmacovigilance, 453-461, 2014
Mandati: US National Institutes of Health
Disponibili pubblicamente: 168
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ...
MEDINFO 2015: eHealth-enabled Health, 574-578, 2015
Mandati: US National Institutes of Health
Validation of a common data model for active safety surveillance research
JM Overhage, PB Ryan, CG Reich, AG Hartzema, PE Stang
Journal of the American Medical Informatics Association 19 (1), 54-60, 2012
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software